Company / Total Assets
Zomedica Corp. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$127.0M
FY2025
5-year range
$127.0M / $279.6M
FY2022-FY2025
Trend
-38.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $280M in FY2022 to $127M in FY2025.
Based on SEC 10-K filings.
$127M in FY2025 with a 3-year CAGR of -23.1%.
Declined from $253M to $127M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Zomedica Corp.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -23.1%, indicating a declining trend.
- In FY2025, total assets decreased 38.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $127.0M | -38.7% |
| FY2024 | $207.4M | -18.1% |
| FY2023 | $253.2M | -9.4% |
| FY2022 | $279.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026